1. Repository of OAI
Ελληνικά   English  

Browsing by Author Kyritsis, A. P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 150 to 169 of 217 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
On M. Krengli, G. Loi, G. Sacchetti et al. Delineation of Target Volume for Radiotherapy of High-Grade Gliomas by (99)mTc-MIBI SPECT and MRI Fusion in: Strahlenther Onkol 2007;183:689-94 (No. 12)Alexiou, G. A.; Tsiouris, S.; Voulgaris, S.; Polyzoidis, K. S.; Kyritsis, A. P.; Fotopoulos, A. D.24-Nov-2015-
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trialsWong, E. T.; Hess, K. R.; Gleason, M. J.; Jaeckle, K. A.; Kyritsis, A. P.; Prados, M. D.; Levin, V. A.; Yung, W. K.24-Nov-2015-
Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivoFueyo, J.; Gomez-Manzano, C.; Yung, W. K.; Liu, T. J.; Alemany, R.; McDonnell, T. J.; Shi, X.; Rao, J. S.; Levin, V. A.; Kyritsis, A. P.24-Nov-2015-
Overexpression of E2F-1 leads to bax-independent cell death in human glioma cellsMitlianga, P. G.; Gomez-Manzano, C.; Kyritsis, A. P.; Fueyo, J.24-Nov-2015-
p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effectMitlianga, P. G.; Sioka, C.; Vartholomatos, G.; Goussia, A.; Polyzoidis, K.; Rao, J. S.; Kyritsis, A. P.24-Nov-2015-
Paraneoplastic neurological syndromes and the role of PET imagingSioka, C.; Fotopoulos, A.; Kyritsis, A. P.24-Nov-2015-
Patient compliance with neuropathic pain treatmentGiannopoulos, S.; Kosmidou, M.; Kyritsis, A. P.24-Nov-2015-
Patient compliance with SSRIs and gabapentin in painful diabetic neuropathyGiannopoulos, S.; Kosmidou, M.; Sarmas, I.; Markoula, S.; Pelidou, S. H.; Lagos, G.; Kyritsis, A. P.24-Nov-2015-
Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survivalPuduvalli, V. K.; Kyritsis, A. P.; Hess, K. R.; Bondy, M. L.; Fuller, G. N.; Kouraklis, G. P.; Levin, V. A.; Bruner, J. M.24-Nov-2015-
Perimetric and peri-papillary nerve fibre layer thickness findings in multiple sclerosisKitsos, G.; Detorakis, E. T.; Papakonstantinou, S.; Kyritsis, A. P.; Pelidou, S. H.24-Nov-2015-
Periventricular nodular heterotopia and epilepsyGiannopoulos, S.; Pelidou, S. H.; Giannopoulou, M.; Tzavidi, S.; Kyritsis, A. P.24-Nov-2015-
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiformeLevin, V. A.; Maor, M. H.; Thall, P. F.; Yung, W. K.; Bruner, J.; Sawaya, R.; Kyritsis, A. P.; Leeds, N.; Woo, S.; Rodriguez, L.; et al.,24-Nov-2015-
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiformeGroves, M. D.; Maor, M. H.; Meyers, C.; Kyritsis, A. P.; Jaeckle, K. A.; Yung, W. K.; Sawaya, R. E.; Hess, K.; Bruner, J. M.; Peterson, P.; Levin, V. A.24-Nov-2015-
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomasFine, H. A.; Figg, W. D.; Jaeckle, K.; Wen, P. Y.; Kyritsis, A. P.; Loeffler, J. S.; Levin, V. A.; Black, P. M.; Kaplan, R.; Pluda, J. M.; Yung, W. K.24-Nov-2015-
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiformeLevin, V. A.; Uhm, J. H.; Jaeckle, K. A.; Choucair, A.; Flynn, P. J.; Yung, W. K. A.; Prados, M. D.; Bruner, J. M.; Chang, S. M.; Kyritsis, A. P.; Gleason, M. J.; Hess, K. R.24-Nov-2015-
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomasLevin, V. A.; Hess, K. R.; Choucair, A.; Flynn, P. J.; Jaeckle, K. A.; Kyritsis, A. P.; Yung, W. K.; Prados, M. D.; Bruner, J. M.; Ictech, S.; Gleason, M. J.; Kim, H. W.24-Nov-2015-
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapyDabaja, B. S.; McLaughlin, P.; Ha, C. S.; Pro, B.; Meyers, C. A.; Seabrooke, L. F.; Wilder, R. B.; Kyritsis, A. P.; Preti, H. A.; Yung, W. K.; Levin, V.; Cabanillas, F.; Cox, J. D.24-Nov-2015-
Prognostic factors in multifocal gliomas: in regard to Showalter et al. (Int J Radiat Oncol Biol Phys 2007;69:820-824)Kyritsis, A. P.; Rao, J. S.; Puduvalli, V. K.24-Nov-2015-
Prognostic significance of MRP5 immunohistochemical expression in glioblastomaAlexiou, G. A.; Goussia, A.; Voulgaris, S.; Fotopoulos, A. D.; Fotakopoulos, G.; Ntoulia, A.; Zikou, A.; Tsekeris, P.; Argyropoulou, M. I.; Kyritsis, A. P.24-Nov-2015-
Prognostic significance of p53 immunoreactivity in patients with gliomaKyritsis, A. P.; Bondy, M. L.; Hess, K. R.; Cunningham, J. E.; Zhu, D.; Amos, C. J.; Yung, W. K.; Levin, V. A.; Bruner, J. M.24-Nov-2015-
Showing results 150 to 169 of 217 < previous   next >